NCT03397771View on ClinicalTrials.gov

DBPC Trial to Evaluate the Safety, Tolerability and Efficacy of Oral Litoxetine in Subjects With Urinary Incontinence

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 3, 2018

Primary Completion Date

May 30, 2019

Study Completion Date

May 30, 2019

Conditions

Urinary Incontinence

Interventions

DRUG

Litoxetine

oral study medication provided in a dose titration manner

DRUG

placebo

placebo medication provided in a dose titration manner

Trial Locations (1)

14221

Upstate Clinical Research Associates LLC, Williamsville

All Listed Sponsors

lead

Ixaltis SA

INDUSTRY

NCT03397771 - DBPC Trial to Evaluate the Safety, Tolerability and Efficacy of Oral Litoxetine in Subjects With Urinary Incontinence | Biotech Hunter | Biotech Hunter